(BHF) Brighthouse Financial - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10922N1037

BHF: Annuities, Life Insurance, Structured Settlements

Brighthouse Financial, Inc. (NASDAQ: BHF) is a U.S.-based financial services company specializing in annuity and life insurance products. Established in 1863, the firm has a long-standing presence in the insurance industry. Headquartered in Charlotte, North Carolina, Brighthouse operates through three distinct business segments: Annuities, Life, and Run-off.

The Annuities segment offers a range of products, including variable, fixed, index-linked, and income annuities. These products are designed to meet contract holders needs for tax-deferred wealth accumulation, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life insurance policies, catering to policyholders seeking financial security and protected wealth transfer solutions.

The Run-off segment is focused on managing legacy products, including structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life policies with secondary guarantees. This segment is essentially winding down older, less core businesses, optimizing capital allocation, and reducing operational complexity.

Brighthouse Financial, Inc. is listed on the NASDAQ exchange under the ticker symbol BHF. As of recent data, the company has a market capitalization of approximately $3.44 billion. Its trailing P/E ratio stands at 12.04, with a forward P/E of 3.03, indicating expectations of significant earnings growth. The price-to-book (P/B) ratio is 0.69, suggesting the market values the company below its book value, while the price-to-sales (P/S) ratio of 0.71 reflects its valuation relative to revenue.

For investors and fund managers, Brighthouse Financials diversified product portfolio and focus on de-risking its balance sheet are key considerations. The companys ability to manage its run-off businesses while growing its core annuity and life insurance segments will be critical to its long-term profitability and shareholder value creation.

Additional Sources for BHF Stock

BHF Stock Overview

Market Cap in USD 2,941m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2017-07-17

BHF Stock Ratings

Growth Rating 62.8
Fundamental 20.0
Dividend Rating 0.0
Rel. Strength -6.53
Analysts 2.7/5
Fair Price Momentum 55.02 USD
Fair Price DCF -

BHF Dividends

No Dividends Paid

BHF Growth Ratios

Growth Correlation 3m -70.4%
Growth Correlation 12m 71%
Growth Correlation 5y 48.6%
CAGR 5y 18.21%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 0.70
Alpha 0.70
Beta 1.007
Volatility 44.67%
Current Volume 622k
Average Volume 20d 856.6k
What is the price of BHF stocks?
As of April 26, 2025, the stock is trading at USD 54.67 with a total of 622,025 shares traded.
Over the past week, the price has changed by +12.05%, over one month by -7.65%, over three months by +7.01% and over the past year by +11.50%.
Is Brighthouse Financial a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Brighthouse Financial is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.95 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHF as of April 2025 is 55.02. This means that BHF is currently overvalued and has a potential downside of 0.64%.
Is BHF a buy, sell or hold?
Brighthouse Financial has received a consensus analysts rating of 2.70. Therefor, it is recommend to hold BHF.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 6
  • Sell: 1
  • Strong Sell: 2
What are the forecast for BHF stock price target?
According to ValueRays Forecast Model, BHF Brighthouse Financial will be worth about 59.4 in April 2026. The stock is currently trading at 54.67. This means that the stock has a potential upside of +8.69%.
Issuer Forecast Upside
Wallstreet Target Price 59.3 8.5%
Analysts Target Price 52.4 -4.2%
ValueRay Target Price 59.4 8.7%